Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 5/20 | 0.50 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.40 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.40 |
| ▸ | GABRE | P78334 | 1/20 | 0.40 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.40 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.40 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.40 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30196749 | 1.00 | KIF11 (0.50) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL1276474 | 0.92 | KIF11 (0.58) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL29939054 | 0.92 | KIF11 (0.58) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL12408493 | 0.92 | KIF11 (0.58) | KIF11AHRGABRPGABRDGABRA1 | |
| Phosphine SCHEMBL28966245 | 0.90 | KIF11 (0.57) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL27033667 | 0.76 | KIF11 (0.40) | KIF11GABRPGABRDGABRA1GABRB1 | |
| Carbazole SCHEMBL7146435 | 0.73 | ALDH1A1 (0.70) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL8079075 | 0.73 | KIF11 (0.66) | KIF11AHRGABRPGABRDGABRA1 | |
| SCHEMBL28217117 | 0.73 | KIF11 (0.66) | KIF11AHRKDM4EKMT2AALDH1A1 | |
| SCHEMBL8082181 | 0.71 | KIF11 (0.64) | KIF11AHRGABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054432-A1 | SYSTEMS AND METHODS FOR DNA READING | Catalog Technologies, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| US-20240391945-A1 | NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE | NITTO DENKO CORPORATION (JP) | 2024-11-28 | — | — | US | disclosed |
| EP-4089099-A1 | NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE | Nitto Denko Corporation (JP) | 2022-11-16 | — | — | EP | disclosed |
| US-20220002790-A1 | NUCLEIC ACID-BASED BARCODING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-01-06 | — | — | US | disclosed |
| EP-3874058-A2 | NUCLEIC ACID-BASED BARCODING | President And Fellows Of Harvard College (US) | 2021-09-08 | — | — | EP | disclosed |
| WO-2021141072-A1 | NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE | 日東電工株式会社 | 2021-07-15 | — | — | WO | disclosed |
| WO-2020131233-A9 | NUCLEIC ACID-BASED BARCODING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-08-13 | — | — | WO | disclosed |
| WO-2020131233-A2 | NUCLEIC ACID-BASED BARCODING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-06-25 | — | — | WO | disclosed |
| US-10513535-B2 | Self-replication of nucleic acid origami tiles | NEW YORK UNIVERSITY (US) | 2019-12-24 | — | — | US | disclosed |
| US-20160215317-A1 | SELF-REPLICATION OF NUCLEIC ACID ORIGAMI TILES | NEW YORK UNIVERSITY | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391945-A1 | NUCLEIC ACID SYNTHESIS METHOD USING SEGMENT-TYPE AMIDITE | RNGTT, NSUN2, ATIC | KIF11 2442/4885AHR 3047/4885GABRP 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.